Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
Authors:
- Roger AbsRARoger Abs
- Maria ThunanderMTMaria Thunander
- Johan VerhelstJVJohan Verhelst
- Miklós I GóthMGMiklós I Góth
- Anton LugerALAnton Luger
- 1 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 168 (3) , 297-305
Abstract
Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.Design and methods: Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.Results: PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.Conclusions: GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.Keywords
This publication has 25 references indexed in Scilit:
- Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement TherapyDiabetes Care, 2011
- Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysisEuropean Journal of Endocrinology, 2011
- Registries as a tool in evidence‐based medicine: example of KIMS (Pfizer International Metabolic Database)Pharmacoepidemiology and Drug Safety, 2007
- Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-AnalysisEpidemiologic Reviews, 2007
- HbA1c as a screening tool for detection of Type 2 diabetes: a systematic reviewDiabetic Medicine, 2007
- Easy SAS Calculations for Risk or Prevalence Ratios and DifferencesAmerican Journal of Epidemiology, 2005
- Thirty Years of Bioethics: The Helsinki Declaration 1964-2003New Review of Bioethics, 2003
- Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 2002
- Effect of Acute Pharmacological Reduction of Plasma Free Fatty Acids on Growth Hormone (GH) Releasing Hormone-Induced GH Secretion in Obese Adults with and without HypopituitarismThe Journal of Clinical Endocrinology & Metabolism, 1998
- Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activityThe Journal of Clinical Endocrinology & Metabolism, 1996